Physiologically based pharmacokinetic modeling to predict human pharmacokinetics of a novel mithramycin analog for Ewing sarcoma
Cancer Chemotherapy and Pharmacology · 12.08.2026 · 96 (1)
DOI: 10.1007/s00280-026-04935-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 12.08.2026. Verfasst von Kumar Kulldeep Niloy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA. Hauptthemen laut MEDLINE: Plicamycin, Models, Biological, Sarcoma, Ewing, Antibiotics, Antineoplastic. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
- Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA.
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY, USA.
- Center for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, KY, USA.
- Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA. mark.leggas@stjude.org.
- Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA. mark.leggas@stjude.org.
ORCID-Profile: Markos Leggas
Förderung
- NCATS NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- Center of Biomedical Research Excellence (COBRE) for Translational Chemical Biology (CTCB)
- National Institute of Food and Agriculture (USDA-NIFACBGP)
- Kentucky Medical Services Foundation Chair in Pharmacy
- University of Kentucky College of Pharmacy
- Markey Cancer Center, University of Kentucky
Zitieren
APA
Niloy, K. K., Horn, J., Bhuiyan, N. H., Bhosale, S. S., Shaaban, K. A., Prisinzano, T. E., Thorson, J. S., Rohr, J., & Leggas, M. (2026). Physiologically based pharmacokinetic modeling to predict human pharmacokinetics of a novel mithramycin analog for Ewing sarcoma. Cancer Chemotherapy and Pharmacology, 96(1). https://doi.org/10.1007/s00280-026-04935-4
Vancouver
Niloy KK, Horn J, Bhuiyan NH, Bhosale SS, Shaaban KA, Prisinzano TE, et al. Physiologically based pharmacokinetic modeling to predict human pharmacokinetics of a novel mithramycin analog for Ewing sarcoma. Cancer Chemotherapy and Pharmacology. 2026;96(1). doi:10.1007/s00280-026-04935-4
BibTeX
@article{Niloy2026,
author = {Niloy, Kumar Kulldeep and Horn, Jamie and Bhuiyan, Nazmul Hasan and Bhosale, Suhas S and Shaaban, Khaled A and Prisinzano, Thomas E and Thorson, Jon S and Rohr, Jurgen and Leggas, Markos},
title = {Physiologically based pharmacokinetic modeling to predict human pharmacokinetics of a novel mithramycin analog for Ewing sarcoma},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2026},
volume = {96},
number = {1},
doi = {10.1007/s00280-026-04935-4}
}
EUVIMED